Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis. (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-7568(21)00169-0
PubMed Identifier: 34401865
Publication URI: http://europepmc.org/abstract/MED/34401865
Type: Journal Article/Review
Volume: 2
Parent Publication: The lancet. Healthy longevity
Issue: 9
ISSN: 2666-7568